First Light Asset Management, LLC — 13F Holdings & Portfolio
CIK 1600004 · latest 13F-HR filed 2026-08-14
First Light Asset Management, LLC manages $1.65B in 13F-reported U.S. long-equity assets across 31 reported positions as of its 2026-06-30 13F-HR filing. Its largest disclosed positions are NEO (10.89%), SIBN (8.06%), AXGN (7.72%). Quarter over quarter (versus its 2026-03-31 filing) the fund opened 2 new positions and exited 6; 24 existing positions rose in reported value and 2 fell.
AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.
Long-equity book
Distinct positions
Filed 2026-08-14
vs 2026-03-31
Portfolio charts
Latest quarter's book, what changed, and how the portfolio has evolved across filings.
Portfolio map
Q2 26Box size = position value; colour = change in share count vs the prior quarter (green added, red trimmed, blue new). Rows split across managers or share classes are combined. Click a box for the stock.
Sector mix
% of 13F valueSectors from each company's SIC code; funds and ETFs grouped separately.
Biggest buys and sells
Q1 26 → Q2 26Estimated from the change in shares held × the quarter-end price, so price moves alone don't count as buying. New and exited positions are included.
13F assets and positions
4 quartersTotal reported 13F value (bars) and number of positions (line) each quarter. Value changes include market moves.
Top positions over time
reported valueThe eight largest current positions, valued at each quarter end.
Concentration
top 10 = 60.7%Cumulative share of the portfolio held in the largest N positions.
As of the firm’s regulatory filing dated Mar 24, 2026.
SUITE 201
EDINA, MN 55435
| Name | Title / Status | Ownership | Type |
|---|---|---|---|
| ARENS, MATHEW, PAUL Control | MANAGING MEMBER, CEO, & SENIOR PORTFOLIO MANAGER since Sep 2013 | 50–75% | Individual |
| MATHEW ARENS 2021 IRREVOCABLE TRUST Control | MEMBER since Dec 2021 | 25–50% | Domestic Entity |
| PETERSON, KURT, TERRY Control | CHIEF FINANCIAL OFFICER & CHIEF COMPLIANCE OFFICER since Mar 2023 | Less than 5% | Individual |
| JOHNSON, BRETT, THOMAS | SENIOR RESEARCH ANALYST & FOUNDING PRINCIPAL since Sep 2018 | Less than 5% | Individual |
| FIRST TRUST COMPANY, LLC Control Indirect owner via MATHEW ARENS 2021 IRREVOCABLE TRUST | TRUSTEE since Oct 2021 | General partner, trustee or manager | Domestic Entity |
Ownership & leadership changes · 15 filings with changes since Aug 29, 2013
From the firm’s regulatory filings, newest first. Dates are filing dates: a filing that no longer lists someone does not say when they left.
- ChangedJOHNSON, BRETT, THOMAS · ownership 5–10% → Less than 5%
- No longer listedCONRAD, PETER, JAMES · CHIEF OPERATING OFFICER/CHIEF FINANCIAL OFFICER & PRINCIPAL · 5–10% · control person · listed since Mar 2019
- ChangedPETERSON, KURT, TERRY · title CHIEF COMPLIANCE OFFICER → CHIEF FINANCIAL OFFICER & CHIEF COMPLIANCE OFFICER
- AddedFIRST TRUST COMPANY, LLC · TRUSTEE · General partner, trustee or manager · indirect via MATHEW ARENS 2021 IRREVOCABLE TRUST · control person
- AddedMATHEW ARENS 2021 IRREVOCABLE TRUST · MEMBER · 25–50% · control person
- ChangedARENS, MATHEW, PAUL · ownership 75% or more → 50–75%
- No longer listedLIEN, JIN, KYONG · CHIEF COMPLIANCE OFFICER · Less than 5% · control person · listed since Mar 2017
- No longer listedTHERKELSEN, DAVID, ALAN · SENIOR PORTFOLIO MANAGER, SENIOR RESEARCH ANALYST & PRINCIPAL · 5–10% · listed since Jan 2020
- AddedPETERSON, KURT, TERRY · CHIEF COMPLIANCE OFFICER · Less than 5% · control person
- ChangedCONRAD, PETER, JAMES · ownership Less than 5% → 5–10%
- AddedTHERKELSEN, DAVID, ALAN · SENIOR PORTFOLIO MANAGER, SENIOR RESEARCH ANALYST & PRINCIPAL · 5–10%
- AddedCONRAD, PETER, JAMES · CHIEF OPERATING OFFICER/CHIEF FINANCIAL OFFICER & PRINCIPAL · Less than 5% · control person
- Listed againJOHNSON, BRETT, THOMAS · SENIOR RESEARCH ANALYST & FOUNDING PRINCIPAL · 5–10%
- No longer listedBEH, BRIAN, CARROLL · PRESIDENT & PRINCIPAL · 5–10% · control person · listed since Jan 2015
- Listed againBEH, BRIAN, CARROLL · PRESIDENT & PRINCIPAL · 5–10% · control person
- No longer listedBEH, BRIAN, CARROLL · PRESIDENT & PRINCIPAL · Less than 5% · control person · listed since Jan 2015
- No longer listedJOHNSON, BRETT, THOMAS · SENIOR RESEARCH ANALYST, CHIEF COMPLIANCE OFFICER, & PRINCIPAL · Less than 5% · control person · listed since Sep 2013
- AddedLIEN, JIN, KYONG · CHIEF COMPLIANCE OFFICER · Less than 5% · control person
Older changes (6 more filings)
- ChangedARENS, MATHEW, PAUL · title MANAGING MEMBER, CEO & SENIOR PORTFOLIO MANAGER → MANAGING MEMBER, CEO, & SENIOR PORTFOLIO MANAGER
- ChangedBEH, BRIAN, CARROLL · title MEMBER, PRESIDENT → PRESIDENT & PRINCIPAL
- ChangedJOHNSON, BRETT, THOMAS · title MEMBER, SENIOR RESEARCH ANALYST, CHIEF COMPLIANCE OFFICER → SENIOR RESEARCH ANALYST, CHIEF COMPLIANCE OFFICER, & PRINCIPAL
- AddedBEH, BRIAN, CARROLL · MEMBER, PRESIDENT · Less than 5% · control person
- ChangedJOHNSON, BRETT, THOMAS · title MANAGING DIRECTOR, CHIEF COMPLIANCE OFFICER → MEMBER, SENIOR RESEARCH ANALYST, CHIEF COMPLIANCE OFFICER
- No longer listedCROWLEY, STEVEN, FRANCIS · MANAGING DIRECTOR OF RESEARCH · Less than 5% · control person · listed since Mar 2014
- AddedCROWLEY, STEVEN, FRANCIS · MANAGING DIRECTOR OF RESEARCH · Less than 5% · control person
- AddedJOHNSON, BRETT, THOMAS · MANAGING DIRECTOR, CHIEF COMPLIANCE OFFICER · Less than 5% · control person
- ChangedARENS, MATHEW, PAUL · title MANAGING MEMBER/CHIEF COMPLIANCE OFFICER → MANAGING MEMBER, CEO & SENIOR PORTFOLIO MANAGER
- ListedARENS, MATHEW, PAUL · MANAGING MEMBER/CHIEF COMPLIANCE OFFICER · 75% or more · control person
Quarter-over-quarter changes
Changes in reported position value vs the prior 13F, so price moves count too, not just shares bought or sold.
Top Adds (vs prior quarter)
- NEOGENOMICS INC$107.0M +148.2%
- APOGEE THERAPEUTICS INC$74.9M +154.4%
- SI-BONE INC$65.0M +96.2%
- ENLIVEN THERAPEUTICS INC$61.1M +772.7%
- GUARDANT HEALTH$40.4M +155.9%
Exited Positions
- CENTESSA PHARMACEUTICALS LIMITED$62.0M
- WAVE LIFE SCIENCES LTD$13.4M
- VERA THERAPEUTICS INC$12.6M
- MIMEDX GROUP INC$11.2M
- SPYGLASS PHARMA INC$9.7M
First Light Asset Management, LLC Holdings (2026-06-30)
Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).
| # | Issuer | Symbol | CUSIP | Value | Weight | Shares | Type |
|---|---|---|---|---|---|---|---|
| 1 | NEOGENOMICS INC | NEO | 64049M209 | $179.2M | 10.89% | 12,279,523 | SH |
| 2 | SI-BONE INC | SIBN | 825704109 | $132.6M | 8.06% | 8,127,985 | SH |
| 3 | AXOGEN INC | AXGN | 05463X106 | $126.9M | 7.72% | 2,748,361 | SH |
| 4 | APOGEE THERAPEUTICS INC | APGE | 03770N101 | $123.5M | 7.50% | 930,289 | SH |
| 5 | PALVELLA THERAPEUTICS INC | PVLA | 697947109 | $118.0M | 7.17% | 771,901 | SH |
| 6 | TWIST BIOSCIENCE CORPORATION | TWST | 90184D100 | $74.9M | 4.55% | 727,933 | SH |
| 7 | ENLIVEN THERAPEUTICS INC | ELVN | 29337E102 | $69.1M | 4.20% | 1,360,750 | SH |
| 8 | GUARDANT HEALTH | GH | 40131M109 | $66.3M | 4.03% | 441,586 | SH |
| 9 | 908 DEVICES INC | MASS | 65443P102 | $54.7M | 3.32% | 6,282,804 | SH |
| 10 | AMYLYX PHARMACEUTICALS INC | AMLX | 03237H101 | $54.3M | 3.30% | 3,023,256 | SH |
| 11 | GENEDX HOLDINGS CORP | WGS | 81663L200 | $53.8M | 3.27% | 783,923 | SH |
| 12 | SIMULATIONS PLUS INC | SLP | 829214105 | $51.1M | 3.11% | 2,792,677 | SH |
| 13 | TANDEM DIABETES CARE INC | TNDM | 875372203 | $51.1M | 3.10% | 3,383,553 | SH |
| 14 | CRINETICS PHARMACEUTICALS INC | CRNX | 22663K107 | $50.9M | 3.10% | 1,360,866 | SH |
| 15 | NEUROPACE INC | NPCE | 641288105 | $45.5M | 2.76% | 2,861,167 | SH |
| 16 | EDGEWISE THERAPEUTICS INC | EWTX | 28036F105 | $44.5M | 2.70% | 1,095,171 | SH |
| 17 | ANAPTYS BIO INC | ANAB | 032724106 | $39.3M | 2.39% | 582,004 | SH |
| 18 | TREVI THERAPEUTICS INC | TRVI | 89532M101 | $39.1M | 2.38% | 2,097,215 | SH |
| 19 | SEPTERNA INC | SEPN | 81734D104 | $32.3M | 1.96% | 963,260 | SH |
| 20 | TRISALUS LIFE SCIENCES INC | TLSI | 89680M101 | $29.8M | 1.81% | 6,552,491 | SH |
| 21 | TECTONIC THERAPEUTICS INC | TECX | 878972108 | $27.5M | 1.67% | 800,726 | SH |
| 22 | HEALTH CATALYST INC | HCAT | 42225T107 | $25.5M | 1.55% | 12,810,861 | SH |
| 23 | BUTTERFLY NETWORK INC | BFLY | 124155102 | $22.2M | 1.35% | 2,642,404 | SH |
| 24 | ESTABLISHMENT LABS HOLDINGS | ESTA | G31249108 | $21.2M | 1.29% | 246,577 | SH |
| 25 | VAXCYTE INC | PCVX | 92243G108 | $20.1M | 1.22% | 345,157 | SH |
| 26 | IRHYTHM TECHNOLOGIES | IRTC | 450056106 | $19.9M | 1.21% | 167,092 | SH |
| 27 | OMNICELL INC | OMCL | 68213N109 | $18.8M | 1.14% | 452,324 | SH |
| 28 | ATRICURE INC | ATRC | 04963C209 | $15.9M | 0.97% | 567,838 | SH |
| 29 | KORU MEDICAL SYSTEMS INC | KRMD | 759910102 | $14.2M | 0.86% | 3,387,902 | SH |
| 30 | TACTILE SYSTEMS TECHNOLOGY INC | TCMD | 87357P100 | $13.8M | 0.84% | 462,562 | SH |
| 31 | RHYTHM PHARMACEUTICALS INC | RYTM | 76243J105 | $9.5M | 0.58% | 85,765 | SH |
| Period | Filed | AUM | Holdings | Accession |
|---|---|---|---|---|
| 2026-06-30 | 2026-08-14 | $1.65B | 31 | 0001999371-26-018014 |
| 2026-03-31 | 2026-05-15 | $1.12B | 35 | 0001999371-26-010896 |
| 2025-12-31 | 2026-02-17 | $1.31B | 33 | 0001999371-26-003511 |
| 2025-09-30 | 2025-11-14 | $1.06B | 41 | 0001999371-25-017920 |
SUITE 201
EDINA, MN 55435